Feature Channels: Immunology

Filters close
Released: 14-Nov-2022 1:05 PM EST
Study Identifies How Stealthy HIV Evades Drugs and Immunity
Duke Health

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.

Released: 14-Nov-2022 10:05 AM EST
Preventing the next pandemic: Leaders of Pacific Rim Universities meet in Bangkok, Thailand
Newswise

Hosted by Chulalongkorn University the APRU APEC University Leaders' Forum 2022 is the first post-pandemic in-person APEC meeting held to foster high-level dialogue between CEOs, policy leaders, university presidents, and top researchers. This event begins Nov 15 at 9 PM EST.

       
Newswise: Focused ultrasound treatment for essential tremor highly effective after 5 years
Released: 10-Nov-2022 4:30 PM EST
Focused ultrasound treatment for essential tremor highly effective after 5 years
University of Virginia Health System

A scalpel-free, high-tech form of brain surgery pioneered at UVA Health offers long-term relief for patients with essential tremor, a common movement disorder, a five-year review shows.

Released: 10-Nov-2022 11:25 AM EST
Immune system reboot in MS patients
University of Zurich

Every day, one person in Switzerland is diagnosed with multiple sclerosis. MS is an autoimmune disease in which the body’s own immune system attacks the myelin sheath of the nerve cells in the brain and spinal cord.

9-Nov-2022 9:00 AM EST
First use of CRISPR to substitute genes to treat patients with cancer
University of California, Los Angeles (UCLA), Health Sciences

For the first time, scientists have used CRISPR technology to insert genes that allow immune cells to focus their attack on cancer cells, potentially leaving normal cells unharmed and increasing the effectiveness of immunotherapy.

Newswise: UTHealth Houston researchers analyze cancer discrepancies among young Black men in the South
Released: 10-Nov-2022 10:35 AM EST
UTHealth Houston researchers analyze cancer discrepancies among young Black men in the South
University of Texas Health Science Center at Houston

Research shows that incidences of Kaposi’s sarcoma among people living with HIV have fallen significantly over the past two decades, but a new evaluation of data led by researchers at UTHealth Houston highlights a significant disparity among one particular demographic – young Black men in the American South.

Newswise: Nanotechnology platform enables immune conversion of cancer cells, sensitizing them to immunotherapy
9-Nov-2022 8:10 PM EST
Nanotechnology platform enables immune conversion of cancer cells, sensitizing them to immunotherapy
University of Texas MD Anderson Cancer Center

A team of researchers at The University of Texas MD Anderson Center has developed a nanotechnology platform that can change the way the immune system sees solid tumor cells, making them more receptive to immunotherapy. The preclinical findings suggest this adaptable immune conversion approach has the potential for broad application across many cancer types.

   
Released: 9-Nov-2022 3:15 PM EST
Knowledge is power. The latest research on arthritis is right at your fingertips
Newswise

Here are some of the latest articles that have been added to the Arthritis channel on Newswise.

8-Nov-2022 4:40 PM EST
Rejuvenated immune cells can improve clearance of toxic waste from brain
Washington University in St. Louis

Rejuvenating the immune cells that live in tissues surrounding the brain improves fluid flow and waste clearance from the brain — and may help treat or even prevent neurodegenerative diseases such as Alzheimer’s and Parkinson’s, according to a study by researchers at Washington University School of Medicine in St. Louis.

Released: 8-Nov-2022 5:00 PM EST
MD Anderson Research Highlights: SITC 2022 Special Edition
University of Texas MD Anderson Cancer Center

This special edition features upcoming presentations by MD Anderson researchers at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, including immunotherapy advances in human papillomavirus (HPV)-positive head and neck cancers, microbiome signatures linked with specialized immune-cell clusters, and promising early activity from novel immunotherapy drugs in advanced melanoma and colorectal cancer.

Released: 8-Nov-2022 12:55 PM EST
Higher-Dose Pneumococcal Vaccines Improve Immune Response in ANCA-associated Vasculitis Patients Receiving Rituximab
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients receiving rituximab for ANCA-associated vasculitis.

Released: 8-Nov-2022 12:45 PM EST
Study Finds Holding Methotrexate for One Week after Flu Vaccine May Be as Effective as a Two-Week Hold
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, showed that discontinuing methotrexate for 1 week after seasonal influenza vaccination provided the same seroprotection as a 2 week discontinuation period in patients with RA.

Newswise: DNA barcoding reveals cancer cells’ ability to evade the immune system
Released: 7-Nov-2022 5:10 PM EST
DNA barcoding reveals cancer cells’ ability to evade the immune system
Garvan Institute of Medical Research

Some cancer cells can deploy parallel mechanisms to evade the immune system’s defences as well as resist immunotherapy treatment, according to a new study from the Garvan Institute of Medical Research.

Newswise: RUDN Researchers Propose a Non-Invasive Method for the Treatment of Endometriosis
Released: 6-Nov-2022 12:05 PM EST
RUDN Researchers Propose a Non-Invasive Method for the Treatment of Endometriosis
Scientific Project Lomonosov

RUDN scientists have shown the possibility of treating endometriosis with the help of macrophages - immune cells that help fight foreign agents. A new approach in the future can replace the standard treatment with surgery.

Released: 4-Nov-2022 6:15 PM EDT
Trinity Team Unearths Potential Secret to Viral Resistance
Trinity College Dublin

Scientists from Trinity College Dublin have unearthed a secret that may explain why some people are able to resist viral infections, having screened the immune systems of women exposed to hepatitis C (HCV) through contaminated anti-D transfusions given over 40 years ago in Ireland.

2-Nov-2022 1:40 PM EDT
Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T
Mount Sinai Health System

Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known as CAR-T only to find their cancer coming back afterwards.

Newswise: New Startup Develops Potential Cure for Type 1 Diabetes
Released: 3-Nov-2022 5:20 PM EDT
New Startup Develops Potential Cure for Type 1 Diabetes
Georgia Institute of Technology

Insulin injections to treat Type 1 diabetes could become a thing of the past, but finding the cure faces many challenges. Although transplanting insulin-producing cells represents a promising approach, this cell therapy requires immunosuppression to prevent rejection. Georgia Tech researchers have developed a new biomaterial called iTOL-100 that could cure Type 1 diabetes by inducing immune acceptance of curative transplanted cells without immunosuppression.

Released: 3-Nov-2022 12:55 PM EDT
Unlocking Hidden Connections Between Cell Death and Inflammation
Texas A&M University

As researchers glean new insights into the dynamic inner world of the human immune system, it has become increasingly clear that mitochondria are critical regulators of how our bodies respond to disease.

Released: 3-Nov-2022 11:00 AM EDT
MD Anderson Research Highlights for November 3, 2022
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.

   
3-Nov-2022 7:05 AM EDT
Study Finds That Patients with Cancer and a Suppressed Immune System Are at High Risk for Severe COVID if Treated with Systemic Drug Therapies
Dana-Farber Cancer Institute

Patients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than those who haven't received such therapies in the three months before their COVID diagnosis, show findings in a new study by researchers at Dana-Farber Cancer Institute, and across the U.S., Canada, and Mexico. Researchers found worse outcomes in both the disease itself as well as the fierce immune response that sometimes accompanies it.

Released: 3-Nov-2022 9:00 AM EDT
Cutting-Edge Combination Shows Promise in Patients with Chemotherapy-Resistant Urothelial Cancer
Wolters Kluwer Health: Lippincott

A combination of two types of cancer-fighting treatments – the immunotherapy agent pembrolizumab and a nanoparticle-bound form of the chemotherapy drug paclitaxel – may provide an urgently needed new treatment approach for patients who do not respond to or can't receive standard chemotherapy for advanced urothelial cancers, reports a preliminary study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Research team discovers central functions of innate immune cells
Released: 3-Nov-2022 3:05 AM EDT
Research team discovers central functions of innate immune cells
Charité - Universitätsmedizin Berlin

Inflammation and increased mucus production are typical symptoms of worm infections and allergies. This immune response involves our innate immune cells, but their exact functions are not yet fully understood.

Released: 2-Nov-2022 7:50 PM EDT
Sepsis and COVID-19 Patients Most at Risk Predicted with Genetic Model
Wellcome Trust Sanger Institute

A new model for understanding which patients with sepsis, Covid-19 and influenza have immune dysfunction and are more likely to suffer poor outcomes has been developed by researchers at the Wellcome Sanger Institute, the University of Oxford, Queen Mary University, Imperial College and their collaborators.

Newswise: Seeing the Immune System in Full Color
Released: 2-Nov-2022 2:10 PM EDT
Seeing the Immune System in Full Color
Sanford Burnham Prebys

The Flow Cytometry Core at Sanford Burnham Prebys is getting a new piece of state-of-the-art research equipment, thanks to a grant from the National Institutes of Health.

Newswise: Hormone Therapy Could Lower Risk of Immunotherapy-Associated Myocarditis in Women
1-Nov-2022 5:00 PM EDT
Hormone Therapy Could Lower Risk of Immunotherapy-Associated Myocarditis in Women
University of Texas MD Anderson Cancer Center

A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center and the University of California San Francisco (UCSF) has discovered the underlying cause of gender differences in immunotherapy-associated myocarditis after immune checkpoint inhibitor (ICI) treatment. Their findings point to possible treatment strategies for this side effect, which disproportionately affects female patients.

   
Newswise: Study Sheds Light on the Reasons Behind Sex Differences in Myocarditis
2-Nov-2022 2:00 PM EDT
Study Sheds Light on the Reasons Behind Sex Differences in Myocarditis
University of California, San Francisco (UCSF)

In the past several years, myocarditis has been of public interest because of cases associated with vaccines for SARS-CoV2 or related conditions. Another form of myocarditis has been linked to immune checkpoint inhibitors (ICIs) used in cancer care. ICI-induced myocarditis is a potentially fatal side effect of ICI usage, and it appears that the adverse cardiac effects may disproportionally impact female patients. This finding is in contrast to other forms of myocarditis, with more cases reported in male patients.

Released: 1-Nov-2022 1:05 PM EDT
骨髓移植的五大关键进步
Mayo Clinic

罗切斯特 , 明尼苏达州 - 六十 前 , , 血液 骨髓 移植 只 种 尝试 救治血癌 试验性 疗法 , 经过 年 发展 , , 如今 已然 种 重要 抗癌 手段。 当前 , 医疗 医疗 医疗

Released: 1-Nov-2022 1:05 PM EDT
Cinco AvançOs Fundamentais Nos Transplantes De Medula óSsea
Mayo Clinic

Nas seis décadas em que o transplante de sangue e medula tem sido usado para tratar pacientes com câncer no sangue, esse tratamento experimental tornou-se uma ferramenta vital de combate ao câncer. A Mayo Clinic, em Rochester, Minnesota, está celebrando a marca de 10 mil transplantes sanguíneos e de medula usados para o tratamento de cânceres sanguíneos e de doenças relacionadas.

Released: 1-Nov-2022 1:00 PM EDT
خمسة تطورات رئيسية في عمليات زراعة نخاع العظم
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا. - على مدار الستة عقود الماضية منذ بداية استخدام عمليات زراعة الدم والنخاع لعلاج المرضى المصابين بسرطان الدم، أصبح هذا العلاج التجريبي أداة حيوية لمكافحة السرطان. تحتفل مايو كلينك في مدينة روتشستر بولاية مينيسوتا بإجراء 10,000 عملية زراعة دم ونخاع لعلاج سرطانات الدم والاضطرابات ذات الصلة.

Released: 1-Nov-2022 12:00 PM EDT
Cinco Avances Clave en Los Trasplantes De MéDula óSea
Mayo Clinic

En las seis décadas posteriores a que se comience a utilizar el trasplante de médula para tratar a pacientes con distintos tipos de cáncer de la sangre, este tratamiento, que en un principio fue experimental, se ha vuelto una herramienta vital para la lucha contra el cáncer. Mayo Clinic de Rochester (Minnesota) celebra el trasplante de sangre y médula ósea número 10 000 utilizado en el tratamiento de distintos tipos de cáncer de la sangre y trastornos relacionados.

Newswise: Efficient Nanovaccine Delivery System Boosts Cellular Immunity
Released: 31-Oct-2022 7:40 PM EDT
Efficient Nanovaccine Delivery System Boosts Cellular Immunity
Osaka Metropolitan University

Cancer immunotherapies, such as immune checkpoint inhibition therapy, have been attracting attention in recent years as new methods for treating cancer.

Released: 31-Oct-2022 1:15 PM EDT
Breast Cancer Research Foundation Renews Support for Mount Sinai Research on Triple-Negative Breast Cancer
Mount Sinai Health System

The Breast Cancer Research Foundation (BCRF) has renewed its funding to Elisa Port, MD, and Hanna Irie, MD, PhD, to study new therapeutic approaches that target aggressive triple-negative breast cancer. The latest installment of $225,000 brings the total to almost $2 million over the past nine years. It will fund research into the immune microenvironment of triple-negative breast cancer in order to identify new strategies to enhance cancer-fighting immune responses for this aggressive breast cancer, which traditionally has few options for treatment.

Newswise: The American Association of Immunologists Announces 2022 Recipients of the Careers in Immunology Fellowships
Released: 31-Oct-2022 12:45 PM EDT
The American Association of Immunologists Announces 2022 Recipients of the Careers in Immunology Fellowships
Federation of American Societies for Experimental Biology (FASEB)

The American Association of Immunologists, a FASEB member society, supports the career development of young scientists by providing eligible principal investigators with one year of salary support for a trainee in their labs.

Newswise: Identity Theft the Secret of the Cat Parasite's Success
Released: 28-Oct-2022 3:50 PM EDT
Identity Theft the Secret of the Cat Parasite's Success
Stockholm University

The parasite Toxoplasma is carried by a large portion of the global human population.

Newswise: Bobby Brooke Herrera Joins Rutgers Global Health Institute as Principal Faculty Member
Released: 28-Oct-2022 2:45 PM EDT
Bobby Brooke Herrera Joins Rutgers Global Health Institute as Principal Faculty Member
Rutgers University-New Brunswick

Research scientist Bobby Brooke Herrera, renowned for developing tools to accelerate diagnosis and treatment of infectious diseases such as COVID-19, has joined Rutgers Global Health Institute.

Released: 28-Oct-2022 8:05 AM EDT
Rx for Healthy Kids: Schedule Routine Immunizations
Children's Hospital Los Angeles

Keeping your child safe and healthy is a multifaceted priority for families, starting with the ride home from the hospital in a properly installed car seat.

Released: 27-Oct-2022 5:45 PM EDT
‘Prime and Spike’ Nasal Vaccine Strategy Helps Combat COVID
Yale University

A Yale-designed nasal vaccine can help bolster immune responses to COVID-19 in previously vaccinated animals and reduce viral transmission, Yale researchers report Oct. 27 in the journal Science.

Released: 27-Oct-2022 3:00 PM EDT
Ancient Viral DNA in Human Genome Guards Against Infections
Cornell University

Viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain present-day viruses, according to new research.

Newswise: Timken Foundation Advances Mission to End Cancer with
$5 Million Gift to James P. Allison Institute
Released: 27-Oct-2022 2:20 PM EDT
Timken Foundation Advances Mission to End Cancer with $5 Million Gift to James P. Allison Institute
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today announced that the Timken Foundation of Canton, Ohio, has made a $5 million commitment to support the James P. Allison Institute at MD Anderson. The gift will support the recruitment of top minds from around the world to help realize the Allison Institute’s goals. By establishing a diverse and inclusive environment of scientists from many fields, the Allison Institute will drive exceptional research that integrates immunobiology across disciplines to develop a comprehensive understanding of the immune system.

Released: 27-Oct-2022 2:05 PM EDT
The Assembly Achieves LEED Gold Status
University of Pittsburgh

University of Pittsburgh, Wexford Science & Technology partner to breathe new life of environmental sustainability into 100-year-old-plus Ford plant.

   
Newswise: New Strategy Shows Potential to Block Nerve Loss in Neurodegenerative Diseases
Released: 26-Oct-2022 6:35 PM EDT
New Strategy Shows Potential to Block Nerve Loss in Neurodegenerative Diseases
Washington University in St. Louis

Two new studies from Washington University School of Medicine in St. Louis support development of a broadly applicable treatment for neurodegenerative diseases that targets a molecule that serves as the central executioner in the death of axons, the wiring of the nervous system.

Released: 26-Oct-2022 6:25 PM EDT
New Gene Editing Strategy Could Lead to Treatments for People Born with Inherited Diseases of the Immune System
University College London

A fault in cells that form a key part of the immune system can be repaired with a pioneering gene editing technique, finds new research demonstrated in human cells and mice, led by UCL scientists.

Newswise: Cecilia Lindestam Arlehamn Wins WHAM Edge Award Funding to Study Sex-Based Differences in Alzheimer's and Parkinson's Diseases
Released: 26-Oct-2022 5:05 PM EDT
Cecilia Lindestam Arlehamn Wins WHAM Edge Award Funding to Study Sex-Based Differences in Alzheimer's and Parkinson's Diseases
La Jolla Institute for Immunology

Cecilia Lindestam Arlehamn, Ph.D., aims to shed light on how sex-based immune system differences may affect the development and progression of these neurodegenerative diseases in men versus women.

Released: 26-Oct-2022 2:45 PM EDT
Cancer Research Institute to Host Annual Virtual Immunotherapy Patient Summit on November 11-12, 2022
Cancer Research Institute

Free online event for cancer patients and caregivers featuring immunotherapy experts and patient advocates taking place Nov. 11-12, 2022.

Newswise:Video Embedded new-lassa-fever-therapy-may-be-on-the-horizon
VIDEO
24-Oct-2022 3:20 PM EDT
New Lassa Fever Therapy May Be on the Horizon
La Jolla Institute for Immunology

The LJI team plans to use their new map of the Lassa virus surface glycoprotein to design a much-needed vaccine.

   
Newswise: Initiation of Intercourse Alters Vaginal Immune Environment
Released: 26-Oct-2022 1:55 PM EDT
Initiation of Intercourse Alters Vaginal Immune Environment
University of Washington School of Medicine

UW Medicine researchers compared vaginal samples collected from 95 young women or adolescent study participants in Kenya before or after they began having sexual intercourse. They found a sharp increase in proteins that control the immune response, including IL-1β, IL-2, and CXCL8, during the first year after becoming sexually active.

Released: 26-Oct-2022 1:25 PM EDT
Multistate study examines mRNA vaccine effectiveness for immunocompromised adults during Omicron BA.4 and BA.5 predominance
Regenstrief Institute

A new study from the Centers for Disease Control and Prevention’s VISION Network presents and analyzes some of the first real-world data on mRNA COVID vaccine effectiveness during Omicron BA.4 and BA.5 predominance for immunocompromised adults.

Released: 26-Oct-2022 12:20 PM EDT
Global Virus Network (GVN) Adds Thailand’s Mahidol University as Newest Member to Combat Viral Threats
Global Virus Network

The Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 39 countries comprising foremost experts in every class of virus causing disease in humans, and the Mahidol University in Thailand announced the addition of the Mahidol Virus Network as GVN’s newest Center of Excellence.



close
2.23259